文献速递胸部CT

胸部CT对有无COVID-19症状个体SARS-CoV-2感染的诊断效能

Diagnostic Performance of Chest CT for SARS-CoV-2 Infection in Individuals with or without COVID-19 Symptoms.
PubMed 文献 · Radiology · 2020-08-10

本前瞻性试验二次分析纳入859例有COVID-19症状者和1138例无症状对照,评估胸部CT联合CO-RADS分类诊断SARS-CoV-2感染的效能。有症状者AUC为0.89,CO-RADS≥3的敏感度89%、特异度73%;无症状者AUC为0.70,敏感度45%、特异度89%。结论认为CT联合CO-RADS在有症状者中诊断效能良好,支持用于分诊,但无症状者敏感度不足以作为一线筛查。

要点

  • 有症状者中CO-RADS≥3诊断SARS-CoV-2感染的敏感度89%、特异度73%,支持用于分诊。
  • 无症状者中CO-RADS≥3敏感度仅45%、特异度89%,不足以作为一线筛查方法。
  • 无症状者偶然发现CO-RADS≥3时应触发呼吸道病原体检测。

核心结论

  • 胸部CT联合CO-RADS在有症状个体中诊断效能良好,支持其用于分诊。
  • 无症状个体中敏感度不足,不足以支持其作为一线筛查方法。
  • 无症状个体偶然检出CO-RADS≥3时应触发呼吸道病原体检测。

研究设计与样本

  • 本研究为前瞻性试验的二次分析,时间范围为2020年3月至2020年4月。
  • 共纳入859例有COVID-19症状的个体和1138例无COVID-19症状、因非COVID-19医疗急症入院的对照参与者。
  • 所有个体均平行进行SARS-CoV-2 PCR检测和胸部CT检查,并按CO-RADS对COVID-19可疑程度进行5级分类(1分为极低可疑,5分为极高可疑)。
  • 以SARS-CoV-2 PCR阳性为参考标准,分别在有症状与无症状个体中计算预测PCR阳性的ROC曲线下面积(AUC),并利用各CO-RADS评分的似然比合理选择诊断阈值。

诊断标准与关键数值

  • 有症状个体(PCR阳性率42%)中,CO-RADS≥3检出PCR阳性的敏感度为89%(319/358),特异度为73%。
  • 无症状个体(PCR阳性率5%)中,CO-RADS≥3检出SARS-CoV-2感染的敏感度为45%(27/60),特异度为89%。
  • 胸部CT联合CO-RADS在有症状个体中AUC为0.89(P<.001),在无症状个体中AUC为0.70(P<.001)。

临床应用与阅片要点

  • 有症状个体中可采用CO-RADS≥3作为分诊阈值,其敏感度89%、特异度73%。
  • 无症状个体中CO-RADS≥3敏感度仅45%,不足以作为一线筛查方法。
  • 无症状个体偶然检出CO-RADS≥3时,应触发呼吸道病原体检测。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The use of chest CT for coronavirus disease 2019 (COVID-19) diagnosis or triage in health care settings with limited severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR) capacity is controversial. COVID-19 Reporting and Data System (CO-RADS) categorization of the level of COVID-19 suspicion might improve diagnostic performance. Purpose To investigate the value of chest CT with CO-RADS classification to screen for asymptomatic SARS-CoV-2 infections and to determine its diagnostic performance in individuals with COVID-19 symptoms during the exponential phase of viral spread. Materials and Methods In this secondary analysis of a prospective trial, from March 2020 to April 2020, parallel SARS-CoV-2 PCR and CT with categorization of COVID-19 suspicion was performed with CO-RADS for individuals with COVID-19 symptoms and control participants without COVID-19 symptoms admitted to the hospital for medical emergencies unrelated to COVID-19. CT with CO-RADS was categorized on a five-point scale from 1 (very low suspicion) to 5 (very high suspicion). Area under the receiver operating curve (AUC) was calculated in symptomatic versus asymptomatic individuals to predict positive SARS-CoV-2 PCR, and likelihood ratios for each CO-RADS score were used for rational selection of diagnostic thresholds. Results A total of 859 individuals (median age, 70 years; interquartile range, 52-81 years; 443 men) with COVID-19 symptoms and 1138 control participants (median age, 68 years; interquartile range, 52-81 years; 588 men) were evaluated. CT with CO-RADS had good diagnostic performance (P < .001) in both symptomatic (AUC, 0.89) and asymptomatic (AUC, 0.70) individuals. In symptomatic individuals (42% PCR positive), CO-RADS 3 or greater detected positive PCR with high sensitivity (89%, 319 of 358) and specificity of 73%. In asymptomatic individuals (5% PCR positive), a CO-RADS score of 3 or greater detected SARS-CoV-2 infection with low sensitivity (45%, 27 of 60) but high specificity (89%). Conclusion CT with Coronavirus Disease 2019 Reporting and Data System (CO-RADS) had good diagnostic performance in symptomatic individuals, supporting its application for triage. Sensitivity in asymptomatic individuals was insufficient to justify its use as a first-line screening approach. Incidental detection of CO-RADS 3 or greater in asymptomatic individuals should trigger testing for respiratory pathogens. © RSNA, 2020 Online supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. De Smet K, De Smet D, Ryckaert T, et al. Diagnostic Performance of Chest CT for SARS-CoV-2 Infection in Individuals with or without COVID-19 Symptoms. Radiology. 2020. PMID: 32776832. doi:10.1148/radiol.2020202708

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。